CIRM refuels with $5.5B and a chance to improve its track record

While a narrow win on California’s Prop. 14 has replenished CIRM’s coffers with $5.5 billion, the stem cell institute will likely have to improve its track record to justify the taxpayer outlay. 

The state is now authorized to issue $5.5 billion in new bonds to fund the California Institute of Regenerative Medicine (CIRM), which ran out of money this summer, with $1.5 billion earmarked for research funding for brain-related diseases...